Keywords: Novartis, R&D, Investment, China

Novartis to invest 1 billion to build largest pharma R&D institute in China in Shanghia

Article | 03 November 2009

Print This

Swiss drug major Novartis is the latest in a string of pharma companies to look to China to sustain their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in